Finance

Lists
Why is PGNY down 2,17%?
Dive Deeper
PGNY:NASDAQ
Progyny Inc
26,86 $
-2,17%
(-0,59) 1D
16 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PGNY...
Open
27,65 $
High
27,78 $
Low
26,74 $
Mkt. cap
2,06 млрд
Avg. vol.
1,18 млн
Volume
0,00
P/E ratio
29,19
52-wk high
33,05 $
52-wk low
16,10 $
EPS
0,92 $
Beta
1,02
Shares outstanding
76,73 млн
No. of employees
846
Open
27,65 $
High
27,78 $
Low
26,74 $
Mkt. cap
2,06 млрд
Avg. vol.
1,18 млн
Volume
0,00
P/E ratio
29,19
52-wk high
33,05 $
52-wk low
16,10 $
EPS
0,92 $
Beta
1,02
Shares outstanding
76,73 млн
No. of employees
846
News stories
From web sources and news partners
Profile
Progyny, Inc. is an American benefits-management company that administers employer-sponsored fertility, family-building and women's-health benefits. The company began offering fertility benefits in 2016. It completed an initial public offering on the Nasdaq in 2019. In 2024, it was described as a pioneer in the field and the only publicly traded fertility-benefits company in the United States. Progyny's services include fertility-treatment benefits, a network of health-care providers, patient-support services and the Progyny Rx pharmacy-benefits program. The company is headquartered in New York City. Wikipedia
About Progyny Inc
CEOPeter Anevski
Employees846
Founded2008 ж. 03 сәу.
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 10 analysts giving stock ratings to PGNY in the past 3 months
Strong buy
Buy
8
Hold
2
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for PGNY in the last 3 months.
Highest
Current 26,86 $
40,00 $ (+48,92%)
Average
34,00 $ (+26,58%)
Lowest
30,00 $ (+11,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stan Berenshteyn
Wells Fargo
Buy
Reiterated
37,00 $
+37,8%
10/16/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
37,00 $
+37,8%
10/15/2026
Peter Warendorf
Barclays
Hold
Maintained
30,00 $
+11,7%
10/15/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
35,00 $
+30,3%
10/08/2026
Constantine Davides
Citizens JMP
Buy
Maintained
33,00 $
+22,9%
09/08/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
30,00 $
+11,7%
08/21/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
36,00 $
+34%
08/13/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
31,00 $
+15,4%
08/06/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
31,00 $
+15,4%
08/07/2026
David Larsen
BTIG
Buy
Maintained
40,00 $
+48,9%
07/24/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
35,00 $
+30,3%
07/13/2026
Unknown Analyst
Goldman Sachs
Buy
Upgraded
30,00 $
+11,7%
05/19/2026
Last report
2026 ж. 06 там.
Fiscal period
Q2 2026
0,55 $ / 0,52 $
+6,16%beat
Revenue / Est. (USD)
350,51 млн / 346,25 млн
+1,23%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
313,35 млн
318,40 млн
328,50 млн
350,51 млн
Cost of goods sold
240,51 млн
241,52 млн
245,43 млн
261,21 млн
Cost of revenue
240,51 млн
241,52 млн
245,43 млн
261,21 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51,31 млн
53,96 млн
47,69 млн
49,30 млн
Operating expense
51,31 млн
53,96 млн
47,69 млн
49,30 млн
Total operating expenses
291,82 млн
295,48 млн
293,12 млн
310,51 млн
Operating income
21,53 млн
22,92 млн
35,38 млн
40,00 млн
Other non operating income
-
-
-
-
EBT including unusual items
23,96 млн
17,85 млн
36,88 млн
41,14 млн
EBT excluding unusual items
23,96 млн
25,55 млн
36,83 млн
41,14 млн
Income tax expense
10,10 млн
5,37 млн
12,65 млн
13,08 млн
Effective tax rate
42,15%
30,07%
34,30%
31,81%
Other operating expenses
-
-
-
-
Net income
13,86 млн
12,48 млн
24,23 млн
28,05 млн
Net profit margin
4,42%
3,92%
7,38%
8,00%
Earnings per share
0,45
0,48
0,50
0,55
Interest and investment income
2,44 млн
2,63 млн
1,45 млн
1,13 млн
Interest expense
-
-
-
-
Net interest expenses
2,44 млн
2,63 млн
1,45 млн
1,13 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
22,80 млн
24,29 млн
36,86 млн
41,63 млн
Gain or loss from assets sale
-
-
52,00 мың
528,00 м.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары